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Abstract—Nitric oxide produced by neuronal nitric oxide syn-
thase (nNOS) in the spinal cord is required for development
of hyperalgesia in inflammatory and neuropathic pain states.
nNOS is expressed by some dorsal horn neurons, and an
early study that used a histochemical method to identify
these cells suggested that they were mainly inhibitory in-
terneurons. We have carried out a quantitative analysis of
nNOS-immunoreactivity in laminae I–III of the rat dorsal horn,
to determine the proportion of inhibitory and excitatory neu-
rons and axonal boutons that express the protein. nNOS was
present in 5% of neurons in laminae I and III, and 18% of
hose in lamina II. Although most cells with strong nNOS
mmunostaining were GABA-immunoreactive, two-thirds of
he nNOS-positive cells in lamina II and half of those in lamina
II were not GABAergic, and some of these expressed protein
inase C (PKC). We estimate that nNOS is present in 17–
19% of the inhibitory interneurons in laminae I–II, and 6% of
those in lamina III. However, our results suggest that nNOS is
also expressed at a relatively low level by a significant pro-
portion (17%) of excitatory interneurons in lamina II. nNOS
was seldom seen in boutons that contained vesicular gluta-
mate transporter 2, which is expressed by excitatory in-
terneurons, but was co-localised with the vesicular GABA
transporter (VGAT, a marker for GABAergic and glycinergic
axons). nNOS was detected in 13% of VGAT boutons in lam-
ina I and in 7–8% of those in laminae II–III. However, it was
only found in 2–4% of the VGAT boutons that were presyn-
aptic to PKC-expressing interneurons in this region. These
esults indicate that nNOS is more widely expressed than
reviously thought, being present in both inhibitory and ex-
itatory neurons. They provide further evidence that axons of
eurochemically defined populations of inhibitory interneu-
on are selective in their post-synaptic targets. © 2011 IBRO.
ublished by Elsevier Ltd.
ey words: nNOS, GABA, PKC, inhibitory interneurons,
confocal microscopy.
The spinal dorsal horn receives sensory inputs that are
organised in a modality-specific way, with nociceptive and
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Open access under CC BY license.thermoreceptive afferents projecting mainly to the superfi-
cial laminae (I–II), and low-threshold mechanoreceptive
afferents arborising in a region that extends from the inner
half of lamina II (lamina IIi) to lamina VI (Light and Perl,
1979; Brown et al., 1981; Sugiura et al., 1986). Laminae
I–III contain numerous densely packed neurons, and al-
though some of those in laminae I and III project to the
brain, the great majority of neurons in each of these lam-
inae have axons that remain in the spinal cord, and are
therefore classified as interneurons (Todd, 2010). In-
terneurons in laminae I–III are thought to modulate trans-
mission of sensory information to the brain and to local
reflex circuits.
Between 30 and 40% of the neurons in laminae I–III
are inhibitory interneurons (Todd and Sullivan, 1990; Pol-
gár et al., 2003). Virtually all of these are GABA-immuno-
reactive and many also contain high levels of glycine,
which suggests that some inhibitory interneurons in this
region use GABA and glycine as co-transmitters. Blocking
GABAergic or glycinergic transmission at the spinal level
leads to tactile allodynia (Yaksh, 1989; Sivilotti and Woolf,
1994), and inhibitory interneurons are thought to have
several specific anti-nociceptive roles (Sandkühler, 2009).
In addition, some of these cells are involved in prevention
of itch (Ross et al., 2010). It is likely that distinct popula-
tions of inhibitory interneurons are responsible for these
various functions. However, because of their morphologi-
cal and electrophysiological diversity (Grudt and Perl,
2002; Heinke et al., 2004; Graham et al., 2007; Maxwell et
al., 2007; Yasaka et al., 2007, 2010; Todd, 2010), it has
proved difficult to identify discrete populations among
these cells. An alternative approach to classification is
based on expression of neurochemical markers, including
neuropeptides and various proteins. For example, neuro-
peptide Y (NPY), galanin, parvalbumin and the neuronal
form of nitric oxide synthase (nNOS) are expressed by
different populations of GABAergic cells in laminae I–III
(Antal et al., 1991; Rowan et al., 1993; Laing et al., 1994;
Tiong et al., 2011).
Nitric oxide (NO) produced by nNOS plays an es-
sential role in inflammatory and neuropathic pain states
(Schmidtko et al., 2009), and it is therefore important to
determine which neurons express nNOS. These were ini-
tially identified with a histochemical reaction for reduced
nicotinamide adenine dinucleotide phosphate (NADPH) di-
aphorase (Valtschanoff et al., 1992a; Spike et al., 1993;
Laing et al., 1994), and subsequently with nNOS antibodies
(Dun et al., 1992, 1993; Valtschanoff et al., 1992b; Zhang et
al., 1993; Herdegen et al., 1994; Saito et al., 1994; Wetts and
Vaughn, 1994; Goff et al., 1998; Ruscheweyh et al., 2006).
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T. C. P. Sardella et al. / Neuroscience 192 (2011) 708–720 709Spike et al. (1993) reported that the great majority of NADPH
diaphorase-positive cells in laminae I–III (90%) were
GABA-immunoreactive, and proposed that nNOS expression
was largely restricted to inhibitory interneurons. This was
consistent with the results of Valtschanoff et al. (1992b), who
had found that all nNOS-immunoreactive axonal boutons in
this region were enriched with GABA, but not glutamate.
There are still significant gaps in our knowledge about
nNOS-expressing neurons in the dorsal horn. For exam-
ple, there is little quantitative information about the propor-
tion of cells or axonal boutons that contain nNOS, and this
is needed in order to determine their contribution to neu-
ronal circuits in the dorsal horn. In addition, Hughes et al.
(2008) detected nNOS in some of the neurons in laminae
Iii–III that expressed protein kinase C (PKC), which is
found in a sub-set of non-GABAergic neurons in this region
(Polgár et al., 1999a), and this suggests that nNOS may be
present in a significant number of excitatory interneurons.
The aims of this study were to establish the proportion of
neurons in laminae I–III that express nNOS and to test the
hypothesis that nNOS is largely restricted to inhibitory
interneurons in this region. We also determined the percent-
age of GABAergic boutons in each lamina that contained
nNOS and tested whether PKC-expressing interneurons,
which have been shown to be innervated by inhibitory in-
terneurons that contain NPY (Polgár et al., 2011), were also
targeted by nNOS-immunoreactive axons.
EXPERIMENTAL PROCEDURES
All experiments were approved by the Ethical Review Process
Applications Panel of the University of Glasgow, and were per-
formed in accordance with the European Community directive
86/609/EC and the UK Animals (Scientific Procedures) Act 1986.
Spinal cords were obtained from 12 adult male Wistar rats
(230–340 g; Harlan, Loughborough, UK). The animals were
deeply anaesthetised with pentobarbitone (300 mg, i.p.; Rhone
Merieux Ltd, Harlow, UK) and perfused through the left cardiac
ventricle with fixative consisting of 4% freshly depolymerised form-
aldehyde in phosphate buffer. In three cases, the fixative also
contained 0.2% glutaraldehyde. The fourth lumbar (L4) segment
of the spinal cord was removed and stored at 4°C for 5–24 h in the
same fixative, before being rinsed in phosphate buffer and cut into
60 m thick transverse or sagittal sections with a vibratome. The
ections were immersed for 30 min in 50% ethanol to enhance
ntibody penetration, and those that had been treated with glutar-
ldehyde-containing fixative were incubated for 30 min in 1%
odium borohydride. Transverse sections were used for all parts
f the study, except the analyses of nNOS in GABAergic boutons
resynaptic to PKC cells, and of the association between gephy-
rin puncta and GABAergic boutons (see below).
All immunocytochemical reactions were carried out at 4°C
and antibodies were diluted in phosphate buffered saline that
contained 0.3 M NaCl, without the addition of blocking serum.
Unless otherwise stated, incubations in primary and secondary
antibodies were for 3 days and overnight, respectively. Species-
specific secondary antibodies (anti-IgG) were raised in donkey
and conjugated to Alexa 488 (Invitrogen, Paisley, UK) or to Rho-
damine Red or DyLight 649 (Jackson ImmunoResearch, West
Grove, PA, USA). These were used at 1:500 (Alexa 488 and
DyLight 649 conjugates) or 1:100 (Rhodamine Red conjugates). tProportion of neurons in laminae I–III that were
nNOS-immunoreactive
Sections from three rats that had been fixed with formaldehyde
were incubated in sheep anti-nNOS (Herbison et al., 1996) (1:
2000) and monoclonal antibody NeuN (Millipore, Watford, UK,
catalogue number MAB377; 1:500), which were revealed with
secondary antibodies conjugated to Alexa 488 and DyLight 649,
respectively. The sections were then incubated for 30 min at 37°C
in Propidium Iodide (Sigma-Aldrich, Poole, UK; 1%) in the pres-
ence of RNase (Sigma-Aldrich; 10 mg/ml) to reveal cell nuclei
(Todd et al., 1998; Polgár et al., 2011).
Two sections from each animal were selected before the
nNOS immunostaining was viewed, and these were scanned with
a Bio-Rad Radiance 2100 confocal microscope equipped with
argon multi-line, green HeNe (543 nm) and red diode (637 nm)
lasers. Sections were scanned through a 40 oil-immersion lens
to generate z-series of 24 optical sections separated by 1 m
z-steps. In order to cover the whole of laminae I–III, it was nec-
essary to scan six to eight z-series from each section.
The resulting confocal scans were analysed with a modifica-
tion (Polgár et al., 2005, 2011) of the disector method (Williams
and Rakic, 1988; Coggeshall, 1992; Bjugn and Gundersen, 1993;
Guillery, 2002). NeuN and Propidium Iodide staining were initially
viewed with Neurolucida for Confocal software (MicroBrightField,
Colchester, VT, USA), and in each z-series the 14th optical sec-
tion was designated as the reference section and the 22nd as the
look-up section. Every optical section in the series was then
viewed and the locations of all neuronal nuclei that were present
in the reference section or appeared in subsequent sections were
plotted onto an outline of the grey matter. All of those cells with
nuclei that were still present in the look-up section were then
excluded, leaving only those for which the bottom surface of the
nucleus was located between the reference and look-up sections.
The depth at which the nucleus of each of these cells was largest
was also recorded, to allow subsequent comparison of the depths
of nNOS and nNOS neurons in the vibratome sections (Polgár
t al., 2011). nNOS-immunoreactivity was then viewed, and the
resence or absence of immunostaining in each of the selected
eurons was noted. Boundaries between laminae I, II and III were
dentified through a dark-field condenser, as described previously
Todd et al., 1998; Polgár et al., 2011) and these were plotted onto
he grey matter outlines. The ventral border of lamina III was
rawn from an atlas of rat spinal cord (Molander et al., 1984). In
his way, we were able to determine the proportion of neurons in
ach lamina that were nNOS-immunoreactive. Since the number
f lamina I neurons included in each of these sections was rela-
ively low (21–39 per section), we also scanned lamina I in an
dditional section from each of the three animals. These were
nalysed in the same way, except that only neurons in lamina I
ere included.
Although the reference and look-up sections are relatively far
part, we ensured that all neurons with nuclei that lay between
hese two planes were included in the sample, by examining every
ptical section between them. No correction was made for tissue
hrinkage, since our aim was to determine the proportion of neu-
ons that were nNOS-immunoreactive, rather than the absolute
umber of cells in a volume of tissue.
Proportion of nNOS neurons that were GABA- or
PKC-immunoreactive
Sections from the three rats fixed with formaldehyde/glutaralde-
hyde were incubated in a cocktail of three primary antibodies:
rabbit anti-GABA (Pow and Crook, 1993) (1:5000), guinea pig
anti-PKC (Yoshida et al., 2006) (1:500) and sheep anti-nNOS
1:2000), which were revealed with secondary antibodies conju-
ated to Alexa 488, Rhodamine Red and DyLight 649, respec-
ively.
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T. C. P. Sardella et al. / Neuroscience 192 (2011) 708–720710Between five and seven vibratome sections were selected
from each of the three animals before nNOS immunostaining was
viewed. Either one or both dorsal horns in these sections were
then scanned with the Radiance confocal microscope through a
40 objective lens to produce a set of six or seven overlapping
image stacks (each consisting of 11–35 optical sections at 1 m
z-separation), such that the whole of laminae I–III was included. In
this way, eight sets of scans (each corresponding to a single
dorsal horn in one vibratome section) were obtained from each of
the three animals. The scans were collected in such a way that the
entire upper surface of laminae I–III in the vibratome section was
included in these z-series.
The confocal image stacks were analysed with Neurolucida
for Confocal. Since penetration of GABA staining was very limited
(see below), only nNOS-immunoreactive neurons for which part of
the nucleus appeared at the upper surface of the vibratome sec-
tion were included. All such cells were initially selected and plotted
onto an outline of the dorsal horn (as described above). The files
corresponding to GABA and PKC were then examined and the
resence or absence of each type of immunoreactivity was re-
orded for each of the selected nNOS cells. In order to determine
hether the sizes of GABA and GABA cells differed, for each
nNOS cell analysed we estimated the distance between the top of
the vibratome section and the bottom of the nucleus, by counting
the number of intervening confocal optical sections. Since the
nucleus could be cut through any part of its z-axis, the mean of this
distance should approach half of the mean z-axis length of the
nucleus in a large sample of cells.
Proportion of GABAergic boutons that were
nNOS-immunoreactive
Antibody against the vesicular GABA transporter (VGAT, also
known at the vesicular inhibitory amino acid transporter) was used
to identify GABAergic axonal boutons (McIntire et al., 1997;
Chaudhry et al., 1998; Polgár and Todd, 2008). Although VGAT is
also expressed by glycinergic boutons (Chaudhry et al., 1998),
most of those in laminae I–III are likely to use GABA as a co-
transmitter, since virtually all glycine-immunoreactive neurons in
this region are also GABA-immunoreactive (Todd and Sullivan,
1990; Polgár et al., 2003). In addition, we have shown that 96–
97% of VGAT boutons in lamina II are associated with punctate
(synaptic) labelling for the 3 subunit of the GABAA receptor
(Polgár and Todd, 2008).
Sections from three of the rats fixed with formaldehyde were
incubated in sheep anti-nNOS (1:2000), rabbit anti-VGAT (Syn-
aptic Systems, Göttingen, Germany, catalogue number 131 002;
1:1000) and guinea pig antibody against the vesicular glutamate
transporter 2 (VGLUT2; Millipore, catalogue number AB5907,
1:5000), and then in secondary antibodies: anti-sheep IgG conju-
gated to Alexa 488, anti-guinea pig IgG conjugated to DyLight 649
and Fab= fragment of donkey anti-rabbit IgG conjugated to Rho-
damine Red (Jackson, 1:100). They were then incubated for 4 h in
unconjugated Fab= fragment of donkey anti-rabbit IgG (Jackson,
1:20), followed by 2 days in rabbit antibody against PKC (Santa
ruz Biotechnology, Santa Cruz, CA, USA, catalogue number
c-211; 1:1000), overnight in biotinylated donkey anti-rabbit IgG
Jackson, 1:500) and then 4 h in streptavidin conjugated to Pacific
lue (Invitrogen, 1:1000).
Two sections from each animal were selected (before nNOS
mmunostaining was viewed) and scanned through a 63 oil-
immersion lens with a Zeiss LSM710 confocal microscope
equipped with argon multi-line, blue diode (405 nm), green DPSS
(561 nm) and red diode (637 nm) lasers. From each section, a set
of z-series was obtained in such a way as to cover a strip 100
m wide through the central part of laminae I–III from one dorsal
orn (Polgár et al., 2011), with each series consisting of 25 optical
ections 0.3 m apart. The scans were analysed with Neurolucida
or Confocal software. The VGAT immunostaining was initiallyiewed and the adjacent scans were aligned such that the full
hickness of laminae I, II and III were seen. Laminar boundaries
ere identified based on scans obtained through a dark-field
ondenser (as described above), and on the position PKC-im-
munoreactive plexus, which corresponds to the inner half of lam-
ina II (Hughes et al., 2003). The boundaries between the laminae
were drawn onto an overlay, and a 55 m square grid was then
uperimposed on the image stacks. A single optical section (the
2th in the z-series) was viewed, and 100 VGAT boutons that
ere present in this section were selected from each of laminae I,
I and III. This was done by choosing the bouton nearest the
ottom right corner of successive grid squares, starting from a
quare at the most dorsal part of each lamina and progressing
hrough the squares in a dorsal-to-ventral, and then a left-to-right,
irection until the 100 boutons had been acquired. Once the
election process was complete, the nNOS immunostaining was
iewed, and the presence or absence of nNOS in each of the
elected boutons was recorded. As this sampling method will be
iased towards VGAT boutons that are more extensive in the
-axis (Guillery, 2002), we estimated the z-axis lengths of all
elected boutons by determining the number of optical sections on
hich they appeared, and multiplying this number by 0.3 m (the
z-spacing).
We also looked for co-localisation of nNOS with VGLUT2 in
these confocal image stacks, although this was not quantified, as
co-localisation was very seldom seen (see below).
nNOS in VGAT axons that were presynaptic to PKC
cells
Sagittal sections from three rats that had been fixed with formal-
dehyde were incubated in the following primary antibody cocktail:
guinea pig anti-PKC (1:500), monoclonal mouse antibody
gainst gephyrin (Synaptic Systems, catalogue number 147 011,
lone 7a; 1:1000), sheep anti-nNOS (1:2000) and rabbit anti-
GAT (1:1000). Gephyrin, nNOS and VGAT were revealed with
econdary antibodies conjugated to Alexa 488, Rhodamine Red
nd DyLight 649, respectively, while PKC was detected with
treptavidin–Pacific Blue conjugate (as above), following applica-
ion of biotinylated anti-guinea pig secondary antibody.
One or two sections from the middle part of the dorsal horn
ere selected from each animal and scans through 20 PKC-
immunoreactive neurons (10 from lamina IIi and 10 from lamina
III) were obtained with the Zeiss LSM710 confocal microscope,
through the 63 oil-immersion lens. Each of these scans con-
sisted of z-series of between 14 and 28 optical sections at 0.5 m
-separation, and in all cases, the cells were selected before the
NOS immunostaining was viewed. Scans were analysed with
eurolucida for Confocal software. For each selected PKC cell,
the soma and any dendrites visible in the scan were first drawn.
Synapses that these cells received from VGAT-immunoreactive
boutons were then identified by the presence of gephyrin puncta
in the membrane of the cell at sites of contact from VGAT boutons
(Polgár et al., 2011), and the locations of these were recorded on
the drawings. nNOS-immunostaining was then viewed, and the
presence or absence of nNOS in each of the VGAT profiles that
were presynaptic to the PKC cells was recorded.
In order to provide further evidence concerning the reliability
f VGAT as a marker for inhibitory boutons, scans from two of the
nimals were analysed to determine the proportion of gephyrin
uncta that were associated with a VGAT-immunoreactive profile.
rom each animal, a set of three confocal z-series, each consist-
ng of 19 optical sections at 0.3 m separation, was scanned
through the 63 oil-immersion lens. These z-series covered a
strip of tissue that included the whole of laminae I–III. The sections
were viewed with Neurolucida for Confocal, and 100 gephyrin
puncta were selected from each lamina in the ninth optical section
in the z-series obtained from each rat. The selection was made
before the VGAT channel was viewed. The VGAT was then re-
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T. C. P. Sardella et al. / Neuroscience 192 (2011) 708–720 711vealed, and the presence or absence of VGAT-immunoreactive
profiles adjacent to each of the selected gephyrin puncta was
recorded.
Characterization of antibodies
The nNOS antibody labels a band of 155 kDa in Western blots of
rat hypothalamus, and immunostaining is abolished by pre-incu-
bation of the antibody with nNOS (Herbison et al., 1996). The
mouse monoclonal antibody NeuN was raised against cell nuclei
extracted from mouse brain and found to react with a protein
specific for neurons (Mullen et al., 1992). We have reported that
NeuN apparently labels all neurons but no glial cells in the rat
spinal dorsal horn (Todd et al., 1998). The GABA antibody was
raised against GABA conjugated to porcine thyroglobulin with
glutaraldehyde, and shown to be specific for GABA, with negligible
cross-reactivity against other amino acids, including glutamate,
aspartate, glycine or taurine (Pow and Crook, 1993). The two
PKC antibodies were raised against peptides corresponding to
he C-terminus of mouse PKC. The guinea pig antibody recog-
ises a single band of appropriate molecular weight in Western
lots of brain homogenates of wild-type, but not PKC/ mice
Yoshida et al., 2006). The rabbit VGAT antibody is directed
gainst amino acids 75–87 of rat VGAT conjugated to keyhole
impet haemocyanin and stains bands of the appropriate molecu-
ar weight in Western blots of rat brain extracts (Takamori et al.,
000). We have reported that immunostaining in the rat dorsal
orn with this antibody is abolished by pre-incubation with the
mmunising peptide at 106 M (Polgár et al., 2011). The gephyrin
antibody was generated against an extract of rat spinal cord
synaptic membranes (Pfeiffer et al., 1984). It has been extensively
characterised and shown to bind to a 93 kDa peripheral mem-
brane protein (gephyrin) in extracts of rat brain membranes
(Becker et al., 1989).
Statistical tests
The Chi-squared test, Mann–Whitney U test or Kruskall-Wallis
ANOVA were used, as appropriate, and P0.05 was taken as
significant.
Fig. 1. nNOS immunostaining in the dorsal horn. A confocal image from
The solid line represents the border of the grey matter, and the dashed
III. There is a plexus of dendrites and axons, most of which are cut in
immunoreactive cell bodies are seen throughout the dorsal horn, and
optical sections at 1 m z-spacing. Scale bar100 m.RESULTS
nNOS immunoreactivity in laminae I–III
The distribution of immunoreactivity in the dorsal horn of
the rat spinal cord was similar to the staining seen previ-
ously with nNOS antibodies, as well as to the distribution of
NADPH diaphorase activity that has been reported
(Valtschanoff et al., 1992a,b; Dun et al., 1993; Spike et al.,
1993; Zhang et al., 1993; Herdegen et al., 1994; Laing et
al., 1994; Saito et al., 1994; Wetts and Vaughn, 1994; Goff
et al., 1998). nNOS-immunoreactive dendrites and axons
formed a dense plexus in the superficial dorsal horn, par-
ticularly in lamina II (Fig. 1). Numerous nNOS-immunore-
active cell bodies were seen in this region, and all of these
were NeuN-positive, indicating that they were neurons
(Fig. 2). In all cases immunostaining was excluded from
the nucleus, but occupied the perikaryal cytoplasm and
often extended into proximal dendrites. The intensity of
nNOS staining varied considerably between cells, with
some showing intense staining and others having moder-
ate or low levels. Results of the quantitative analysis of the
proportion of neurons that were nNOS-immunoreactive are
shown in Table 1, and an example of the results obtained
with the disector method is illustrated in Fig. 3. nNOS was
found in approximately 4% of neurons in lamina I, 18% of
those in lamina II and 5% of those in lamina III.
For each of the cells included in the disector sample,
we recorded the depth in the z-series at which the nucleus
appeared largest. For the nNOS-immunoreactive cells, the
range of depths was 6–17 m below the top surface
(median 12, n148 cells), while for the non-immunoreac-
tive cells the range was from 4 to 21 m below this surface
median 11, n1238), and these values did not differ
ignificantly (P0.21, Mann–Whitney U test). This sug-
verse section through the L4 segment immunostained to reveal nNOS.
w the approximate positions of the ventral borders of laminae I, II and
ction, that is most prominent in the inner part of lamina II. Scattered
these are indicated with arrowheads. The image is a projection of 20a trans
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T. C. P. Sardella et al. / Neuroscience 192 (2011) 708–720712gests that there was no reduction in the proportion of
neurons that were nNOS-immunoreactive at deeper levels
within the z-series, which would have occurred if there was
limited penetration of nNOS immunostaining into the sec-
tions.
nNOS, GABA and PKC
The laminar distribution of GABA immunostaining seen in
these sections was very similar to that observed previously
in semithin resin-embedded sections (Todd and McKenzie,
1989; Todd and Sullivan, 1990; Spike et al., 1993; Polgár
et al., 2003). However, as reported previously (Sloviter et
al., 2001) its penetration into vibratome sections was ex-
tremely limited (5 m from the section surface). For this
eason, only nNOS-positive cells for which the soma ap-
eared at the upper surface of the vibratome section were
nalysed for GABA or PKC immunoreactivity. The distri-
ution of PKC was the same as that reported previously
Mori et al., 1990; Malmberg et al., 1997; Polgár et al.,
999a; Hughes et al., 2008), with numerous immunoreac-
ive cell bodies in the inner half of lamina II and the dorsal
art of lamina III, and scattered cells elsewhere. As re-
orted previously, very few PKC-immunoreactive cells
ere labelled with the GABA antibody (Polgár et al.,
999a).
Quantitative data from this part of the study are shown
n Table 2. All of the nNOS-positive cells in lamina I were
Fig. 2. Confocal images showing nNOS-immunoreactive neurons in
segment immunostained for nNOS (green). (b) The same field scan
Neuronal nuclei appear purple, while the nuclei of non-neuronal cells (g
between laminae I, II and III indicated with dashed lines and the dorsal
are visible. Some of these show strong immunoreactivity (two marked w
with arrowheads). The insets in (a) show these two weakly immunor
nNOS-containing dendrites and axons, most of which are cut in cross
Table 1. Percentages of neurons in laminae I–III that were
nNOS-immunoreactive
Lamina Number of
neurons counted
Number of
nNOS cells
% of neurons
that were nNOS
I 80.3 (68–91) 3.3 (2–4) 4.2 (3.2–5.1)
II 216.3 (201–232) 38 (32–42) 17.6 (13.8–20.5)
III 165.3 (141–182) 8 (6–10) 4.8 (3.5–5.6)
In each case the mean values for the three animals are shown, with
the range in parentheses.ABA-immunoreactive (Fig. 4a–c), and none of these was
KC-immunoreactive. Although only 20 nNOS cells were
ampled in lamina I in this part of the study, the presence
f GABA-immunostaining in all of these cells indicates that
t least the great majority of the nNOS cells in this lamina
re GABAergic. In lamina II, 37% of the nNOS neurons
ampled were GABA-immunoreactive (Fig. 4d–f), 32%
ere PKC-immunoreactive, with 1% containing both
GABA- and PKC-immunoreactivity, and 32% containing
neither. The majority of nNOS cells in lamina III were
positive for GABA (50%) and/or PKC (53%), with 8%
having both types of immunoreactivity, and only 6% having
neither (Fig. 5a–d). Although many of the nNOS cells in
each lamina were clearly GABA-positive, the intensity of
GABA immunostaining in these cells was generally weaker
than that seen in many of the surrounding neurons that
lacked nNOS (Fig. 4). The mean distance between the top
of the vibratome section and the bottom of the nucleus for
the GABA lamina II neurons was 6.83 m (range 1–14
m, median 7 m, n159), while that for the GABA cells
in this lamina was 5.83 m (range 1–13 m, median 6 m,
n273), and these values differed significantly (P0.005,
erficial dorsal horn. (a) Part of a transverse section through the L4
veal NeuN (blue) and the nuclear stain Propidium Iodide (PI, red).
apillary endothelial cells) are red. (c) The merged image, with borders
e grey matter shown with a solid line. Several nNOS-positive neurons
s), while others are much more weakly immunoreactive (two indicated
ells at higher magnification. The small green profiles correspond to
The images are from a single optical section. Scale bar50 m.
Fig. 3. The distribution of nNOS-immunoreactive and non-immunore-
active neurons in laminae I–III. A plot of all of the neurons included in
the disector sample from one of the sections that was used to deter-
mine the proportion that contained nNOS. nNOS-positive cells arethe sup
ned to re
lia and c
edge of th
ith arrow
eactive cshown as filled circles and nNOS-negative cells as open circles.
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T. C. P. Sardella et al. / Neuroscience 192 (2011) 708–720 713Mann–Whitney U test). For lamina III neurons, the corre-
sponding values were 5.32 m (range 1–12 m, median 5
m, n59; GABA cells) and 5.98 m (range 1–12 m,
median 6 m, n61; GABA cells), and these values did
ot differ significantly (P0.15, Mann–Whitney U test).
he significant size difference between GABA and
ABA nNOS nuclei in lamina II suggests that our sam-
ling method was biased towards the GABA cells, as
hese were on average 17% longer in the z-dimension.
ince the extent of the bias is directly related to this differ-
nce in z-axis length, we estimate that the true proportion
f lamina II nNOS neurons that are GABAergic is 33.2%,
ssuming that the “corrected” number of GABA-positive
ells that would have been sampled would be 136 (i.e.
59/1.17), with the same number of GABA-negative cells
273) being included.
Table 2. Percentages of nNOS neurons sampled in laminae I–III that
Lamina Number of nNOS
cells counted
% that were GABA
I 6.7 (3–9) 100 (100–100)
II 144 (121–164) 36.7 (34.7–40.1)
II 40 (30–47) 49.6 (46.5–53.3)
In each case the mean values for the three animals are shown, wit
Fig. 4. nNOS and GABA immunostaining in laminae I and II. (a–c) pa
nNOS-positive neuron that is also GABA-immunoreactive is marked
markers. Note that these appear as empty spaces in the GABA-st
(GABA-containing axons and dendrites) in the surrounding neuropil. (d
is GABA-immunoreactive is shown with an arrow, and some of the
asterisks. Arrowheads show two cells with very weak nNOS staining th
than that seen in some of the nearby neurons. Images are from 4 (a–c) and 7In order to compare the nNOS immunostaining inten-
ity between the cells that were GABA-immunoreactive
nd those that were not, all of the selected nNOS cells that
ere sampled in these three animals were assigned a
core of 4 (very strong), 3 (medium), 2 (weak) or 1 (very
eak) staining for nNOS. To avoid bias, this was carried
ut before GABA immunoreactivity was viewed. Of the 572
NOS-positive neurons analysed, 44% were classified as
ery weak, 22% as weak, 15% as moderate and 20% as
trong (Table 3). The proportions of neurons in each of
hese groups that were GABA-immunoreactive were 24%,
2%, 56% and 90%, respectively, and these were signifi-
antly different (P0.001, Chi-squared test). We also de-
ermined the proportions of cells in each group that were
KC-immunoreactive, and found that these were 33%,
BA- and/or PKC-immunoreactive
ere PKC % that were GABA
and PKC
% that were GABA
and PKC
) 0 (0–0) 0 (0–0)
4–47.9) 1 (0–1.7) 32 (19–40.2)
7–62.8) 8.2 (6.4–11.6) 6.1 (2.3–12.8)
ge in parentheses.
a I immunostained to reveal nNOS (magenta) and GABA (green). An
arrow. Asterisks show examples of cells that are negative for both
age, due to the presence of numerous immunoreactive structures
f lamina II stained in the same way. Again, an nNOS-positive cell that
t are negative for both types of immunoreactivity are indicated with
BA-negative. Note that the level of GABA in the nNOS cells is weakerwere GA
% that w
0 (0–0
32.3 (24.
52.5 (44.rt of lamin
with an
ained im
–f) part o
cells tha
at are GA(d–f) optical sections at 0.3 m z-separation. Scale bar20 m.
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Fig. 5. nNOS, PKC and GABA immunostaining. (a–c) show part of
amina III scanned to reveal nNOS (blue), PKC (red) and GABA
green), respectively, while (d) is a merged image of the same field.
cell that is strongly positive for nNOS, negative for PKC and
ositive for GABA is indicated with an arrow. Four cells that are
egative for GABA and nNOS are marked with asterisks, and two of
hese are PKC-immunoreactive. Another PKC cell that is positive
or nNOS and negative for GABA is indicated with an arrowhead.
e–g) comparison of immunostaining with rabbit (rb, green) and
uinea pig (gp, magenta) antibodies against PKC in lamina II
shows that both antibodies are detecting identical structures, which
therefore appear white in the merged image. The images in (a–d)
are from five optical sections at 0.3 m z-separation, while those in
(e–g) are from a single optical section. Scale bar20 m.were significantly different (P0.001, Chi-squared test). dTo compare immunostaining with the two PKC anti-
odies, we had incubated sections from a rat fixed with
ormaldehyde in the rabbit and guinea pig anti-PKC,
hich were revealed with Alexa 488 and Rhodamine Red,
espectively. Examination of these sections revealed that
dentical structures were labelled with each antibody (Fig.
e–g).
NOS, VGAT and VGLUT2
xamination of sections that had been reacted for nNOS,
GAT, VGLUT2 and PKC showed that nNOS immuno-
staining was present in some of the VGAT-immunoreactive
boutons in each lamina (Fig. 6). Quantitative analysis of
100 boutons per lamina in six sections (two from each of
three rats) revealed that mean percentage of VGAT bou-
tons that were nNOS-immunoreactive was 13.2% (range
7–18%) for lamina I, 8.2% (range 4–10%) for lamina II and
7% (range 3–10%) for lamina III. The mean of the z-axis
lengths for the nNOS-positive VGAT boutons was 1.45 m
(range 0.6–3.6 m, median 1.5 m, n170), while that for
he nNOS-negative boutons was 1.41 m (range 0.3–3.6
m, median 1.5 m, n1630), and these did not differ
significantly (P0.1, Mann–Whitney U test). This indicates
that a size difference between the two populations is un-
likely to have distorted our estimate of the proportions that
contained nNOS.
Although weak nNOS staining was very occasionally
seen in VGLUT2-immunoreactive boutons, this was not
analysed quantitatively as preliminary observation re-
vealed that these constituted less than 1% of the VGLUT2
boutons in each lamina.
nNOS in VGAT boutons that were presynaptic to
PKC cells
ltogether, 830 VGAT boutons that contacted gephyrin puncta
n the 30PKC lamina II neurons (10–45 contacts per cell) and
840 VGAT boutons that contacted gephyrin puncta on the 30
PKC lamina III neurons (17–47 contacts per cell) were
analysed. The percentage of these that were nNOS-immu-
noreactive varied from 0 to 14.3% (mean 2.2%, median
0%, n30) for the lamina II neurons and 0–11.8% (mean
4.2%, median 3.9%, n30) for the lamina III neurons.
Kruskall–Wallis one-way ANOVA revealed that there was
a significant difference in the percentage of VGAT boutons
Table 3. Strength of nNOS immunostaining in GABA and PKC
cells in laminae I–III
nNOS strength Number % GABA % PKC
1 251 24% 33%
2 123 22% 57%
3 85 56% 39%
4 113 90% 9%
Total 572
The table shows the number of nNOS neurons of each staining
intensity, and the percentages of these that were immunoreactive for
GABA or PKC (data pooled from three animals). nNOS strength was
efined as very weak (1), weak (2), medium (3) or strong (4).
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T. C. P. Sardella et al. / Neuroscience 192 (2011) 708–720 715that were nNOS-immunoreactive between those that con-
tacted the PKC cells and those in the general population
in laminae II and III (P0.001). Post hoc pairwise compar-
isons revealed a significant difference between the VGAT
boutons on the PKC cells and those in the general pop-
lation within lamina II (P0.005, Mann–Whitney U test)
ut not in lamina III (P0.1). An example of one of the
NOS/VGAT boutons that contacted a PKC cell at a
ephyrin punctum is shown in Fig. 7.
ssociation between gephyrin puncta and VGAT
outons
xamination of the sections stained for VGAT, gephyrin,
NOS and PKC showed that the great majority of gephyrin
uncta were associated with VGAT boutons (Fig. 7a, b).
uantitative analysis revealed that 96.5% of the selected
ephyrin puncta in laminae I–III were in contact with a VGAT
rofile (range 95.3–97.7, n300 puncta from each of two
ats). Since gephyrin is associated with both GABAergic and
lycinergic synapses (Fritschy et al., 2008), this finding
Fig. 6. nNOS and VGAT in lamina II. Confocal images from lamina
(magenta), together with a merged image (c). Three boutons that ar
surrounded by many VGAT boutons that lack nNOS, and by scattered
and intervaricose portions of axons. The images are projections of fo
Fig. 7. nNOS in a VGAT bouton that is presynaptic to a PKC neuro
to reveal nNOS (green), VGAT (red), PKC (blue) and gephyrin
mmunoreactive neuron in lamina III. Three gephyrin puncta in the mem
re not associated with the cell are also visible. (b, c) Each of the gephy
outon, which is presumably forming an axosomatic synapse (at the s
hat are seen in this field are also in contact with VGAT boutons. (d, e) t
rrow is nNOS-immunoreactive, and its position is shown with an arrowhead in (trongly suggests that VGAT, which is known to transport
oth GABA and glycine (Chaudhry et al., 1998), is a reliable
arker for the axonal boutons that use either or both of these
ransmitters in laminae I–III of the dorsal horn.
DISCUSSION
The main findings of this study are: (1) that nNOS is
present in cell bodies of 4–5% of neurons in laminae I and
III, and 18% of those in lamina II; (2) that two-thirds of
nNOS-containing neurons in lamina II and half of those in
lamina III are not GABA-immunoreactive, with many ex-
pressing PKC; and (3) that nNOS can be detected in
–13% of VGAT boutons in these laminae but only in
–4% of those that are presynaptic to PKC-immunoreac-
tive neurons in laminae II and III.
Comparison with previous findings
In a previous study we combined post-embedding immu-
nocytochemistry for GABA and glycine with NADPH diaph-
ansverse section reacted to reveal (a) nNOS (green) and (b) VGAT
oreactive with both antibodies are indicated with arrows. These are
ofiles that are not VGAT-immunoreactive. The latter include dendrites
sections at 0.3 m z-spacing. Scale bar10 m.
gittal section. Confocal images from a single optical section scanned
a) The optical section passes through the cell body of a PKC-
this cell are indicated with arrows. Several other gephyrin puncta that
in the membrane of the PKC cell is associated with a VGAT-positive
gephyrin punctum). Note that virtually all of the other gephyrin puncta
bouton adjacent to the gephyrin punctum that is marked by the middleII in a tr
e immun
nNOS prn in a sa
(white). (
brane of
rin puncta
ite of the
he VGATb–f). (f) a merged image showing all four channels. Scale bar10 m.
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(112/123, 91%) of diaphorase-positive neurons in laminae
I–III were GABA-immunoreactive, with many also showing
glycine immunoreactivity (data from Fig. 1 of Spike et al.,
1993). However, in the present study, only around a third
of the nNOS neurons in lamina II and half of those in
amina III were GABA-immunoreactive. Immunofluores-
ent detection of GABA simultaneously with other antigens
ay be compromised by the need to avoid fixation with
igh concentrations of glutaraldehyde (Sloviter et al.,
001), and alternative approaches, such as in situ hybri-
isation for the 67 kDa molecular weight isoform of glu-
amic acid decarboxylase (GAD67) and viewing tissue
rom GAD67-green fluorescent protein (GFP) knock-in
ice, have therefore been employed to reveal GABAergic
ells (Huang et al., 2008, 2010). However, the pattern of
ABA immunostaining in the present study was very sim-
lar to what we saw previously (Spike et al., 1993), and it is
nlikely that the discrepancy between the two studies re-
ults from loss of sensitivity of the GABA immunostaining.
more likely explanation is that in our previous study we
ailed to identify cells that contained a low concentration of
NOS, due to insensitivity of the diaphorase reaction. Con-
istent with this, 90% of cells classified as strongly immu-
oreactive for nNOS in the present study were GABA-
ositive. It is therefore likely that only cells with high levels
f nNOS were identified as NADPH diaphorase-positive in
ur previous study.
Because all of the neurons in laminae II–III that are not
ABAergic and/or glycinergic are thought to be glutama-
ergic (Todd, 2010; Yasaka et al., 2010), our results sug-
est that many excitatory cells in this region express
NOS. One easily recognised group of excitatory interneu-
ons consists of cells that express PKC (Mori et al., 1990;
almberg et al., 1997; Polgár et al., 1999a). Hughes et al.
2008) identified a few neurons in this region that were
mmunoreactive for both nNOS and PKC, but concluded
that co-localisation was a relatively rare event. In contrast,
we found that 30% of nNOS cells in lamina II and 50%
of those in lamina III were PKC-immunoreactive. Since
e used the same nNOS antibody as Hughes et al., and
he rabbit PKC antibody that they used stains identical
tructures to the guinea pig PKC antibody, it is likely that
he finding of frequent co-localisation in the present study
as due to the greater sensitivity of confocal microscopy.
Table 4. Estimated percentages of GABAergic neurons that contain n
Lamina % of
neurons that
are nNOS
% of nNOS
neurons that
are GABA
% of neurons
that are nNOS/
GABA
I 4.2 100 4.2
II 17.6 33.2d 5.8
III 4.8 49.6 2.4
a The percentages of neurons that are GABAergic are taken from data f
t al. (2003).
b Data from Polgár et al. (2011).
c Data from Tiong et al. (2011).
d The estimate for the percentage of nNOS neurons in lamina II that a
ABA and GABA neurons among the nNOS-immunoreactive cells in this laughes et al. may have missed weak immunostaining with
ne of the antibodies, particularly in cells that were strongly
uorescent with the other one. In fact, most (78%) of the
KC-immunoreactive neurons that were double-labelled
n our study were classified as weakly or very weakly
abelled for nNOS.
Ruscheweyh et al. (2006) estimated that 1–3% of lam-
ina I neurons were nNOS-immunoreactive, based on un-
corrected profile counts. The somewhat higher value that
we found (4%) probably results from our use of confocal
microscopy and a stereological method.
Expression of nNOS in GABAergic and
non-GABAergic neurons
We have previously reported that in the L4–5 segments of
Sprague–Dawley rats 24.8%, 31.3% and 40.2% of the
neurons in laminae I, II and III are GABA-immunoreactive
(Polgár et al., 2003). If we assume similar values in Wistar
rats, then we can estimate the proportion of GABAergic
neurons in each lamina that express nNOS, based on the
percentage of neurons that were nNOS-immunoreactive
and the proportion of these that were GABA-immunoreac-
tive (Table 4). According to this estimate, nNOS is likely to
be present in 17%, 19% and 6% of the GABAergic
neurons in laminae I, II and III, respectively. We have
shown that nNOS, NPY, galanin and parvalbumin are
present in non-overlapping neuronal populations in lami-
nae I and II (Laing et al., 1994; Tiong et al., 2011), and
have recently estimated the proportion of GABAergic neu-
rons in each lamina that contain NPY or galanin (Polgár et
al., 2011; Tiong et al., 2011). Comparison of these esti-
mates indicates that neurons that contain nNOS, NPY or
galanin constitute 67% of the inhibitory interneurons in
lamina I and 46% of those in lamina II (Table 4). Cells that
contain these three compounds are much less common in
lamina III, and we found that most galanin cells in lamina III
are also nNOS-immunoreactive (Tiong et al., 2011). Par-
valbumin-containing cells are present in laminae II and III,
but the proportion of GABAergic neurons in these laminae
that contain parvalbumin is not known.
Glutamatergic cells make up around 69% of the neu-
ronal population in lamina II (Polgár et al., 2003). Based on
our finding that nNOS was present in 18% of lamina II
neurons and that 67% of these were not GABA-immuno-
Y or galanin
ons
rgica
% of GABAergic
neurons that
contain nNOS
% of GABAergic
neurons that
contain NPYb
% of GABAergic
neurons that
contain galaninc
16.9 23.4 26.4
18.7 17.3 9.9
5.9 9.5 4.9
–5 segments of three naive Sprague–Dawley rats examined by Polgár
-immunoreactive has been corrected for the size difference betweenNOS, NP
% neur
that are
GABAe
24.8
31.3
40.2
or the L4
re GABA
mina (see text).
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T. C. P. Sardella et al. / Neuroscience 192 (2011) 708–720 717reactive, we estimate that 17% of the excitatory interneu-
rons in this lamina express nNOS. A similar calculation
suggests that 4% of glutamatergic neurons in lamina III
ontain nNOS. In lamina III nNOS was found mainly in
ABA- or PKC-immunoreactive neurons, with only 6% of
he cells being negative for both markers. However, in
amina II, around 32% of the nNOS neurons were neither
ABA- nor PKC-immunoreactive. This implies that nNOS
is expressed in several neuronal populations: GABAergic
inhibitory interneurons throughout laminae I–III, and at
least two types of excitatory interneuron in laminae II–III:
those with and those without PKC.
NOS-immunoreactive axons
lthough our results indicate that many glutamatergic cells
n laminae II and III express nNOS, nNOS-immunoreactiv-
ty was very seldom seen in boutons that contained
GLUT2, which is expressed by glutamatergic neurons in
his region (Oliveira et al., 2003; Todd et al., 2003; Alvarez
t al., 2004; Llewellyn-Smith et al., 2007; Yasaka et al.,
010). This is consistent with the results obtained with
lectron microscopy by Valtschanoff et al. (1992b), who
eported that all nNOS-containing axon terminals in lamina
I are GABA-immunoreactive. The most likely explanation
s that nNOS is only present at detectable levels in axons
f cells that have a high concentration in the soma, most of
hich are GABAergic. Since the majority (90/112) of
ABA-immunoreactive NADPH diaphorase-positive neu-
ons in laminae I–III were also glycine-immunoreactive
Spike et al., 1993), it is likely that many of the nNOS/
VGAT boutons use GABA and glycine as co-transmitters.
However, for convenience they will be referred to as
GABAergic.
Immunocytochemical studies have provided evidence
for innervation of different types of dorsal horn neuron by
specific neurochemical types of GABAergic axon. For ex-
ample, we reported that 27% of gephyrin puncta (pre-
sumed inhibitory synapses) on giant lamina I spinopara-
brachial neurons were associated with nNOS-immunore-
active boutons, while for lamina I neurons with the NK1
receptor (NK1r), which are also likely to have been projec-
tion cells (Al Ghamdi et al., 2009), nNOS boutons were
present at only 3% of their gephyrin puncta (Puskár et al.,
2001). Since the present study shows that 13% of VGAT
boutons in lamina I are nNOS-immunoreactive, this indi-
cates that nNOS-containing interneurons preferentially in-
nervate the giant cells, but are substantially under-repre-
sented among inhibitory inputs to NK1r-expressing neu-
rons in this lamina. NK1r-expressing projection neurons in
lamina III also receive very few contacts from nNOS-im-
munoreactive boutons, but are targeted by axons that
contain NPY and GABA, which provide 30% of their
inhibitory synapses (Polgár et al., 1999b, 2011). We re-
cently reported that excitatory interneurons with PKC in
amina IIi receive 36% of their inhibitory input from NPY/
ABA axons (Polgár et al., 2011). The inputs from NPY-
ontaining axons to both the lamina III NK1r projection
eurons and the PKC interneurons represent a selectiveinnervation, since only 15% of VGAT boutons in lamina II,nd 5% of those in lamina III, were NPY-immunoreactive.
he present results indicate that although nNOS-containing
ABAergic boutons occasionally form synapses with the
KC cells, they are significantly under-represented among
he inhibitory inputs to those in lamina II.
unctions of nNOS in the superficial dorsal horn
O generated by nNOS acts on soluble guanylate cyclase
sGC) to produce cyclic guanosine monophosphate (cGMP)
Garthwaite, 2008). Although NO and cGMP in the spinal
ord have no effect on acute pain thresholds, studies with
OS inhibitors and knockout mice indicate that NO derived
rom nNOS is required for development and maintenance
f hyperalgesia in inflammatory and neuropathic pain
tates (Malmberg and Yaksh, 1993; Meller and Gebhart,
993; Osborne and Coderre, 1999; Luo and Cizkova,
000; Tao et al., 2004; Chu et al., 2005; Boettger et al.,
007; Guan et al., 2007). There is also evidence that NO
an have anti-nociceptive effects within the spinal cord
Zhuo et al., 1993; Iwamoto and Marion, 1994), and it
as been suggested that the concentration determines
hether it is pro- or antinociceptive (Schmidtko et al.,
009).
NO acts both pre- and postsynaptically (Garthwaite,
008). Presynaptic actions involve release from nNOS-
ontaining axons, leading to depolarisation or hyperpolari-
ation of the postsynaptic target (Garthwaite, 2008). A
ostsynaptic mechanism can result from activation of
NOS in cell bodies or dendrites by Ca2 entering through
MDA receptors, and there is thought to be a direct inter-
ction between nNOS and the NMDA receptor NR2B sub-
nit (Brenman et al., 1996), which is present at many
lutamatergic synapses in the superficial dorsal horn
Nagy et al., 2004). It has been proposed that in this
ituation NO can act as a retrograde signal, leading to
rolonged changes in synaptic strength (Steinert et al.,
010), and there is evidence that it is required for devel-
pment of long-term potentiation in the superficial dorsal
orn (Zhang et al., 2005; Ikeda et al., 2006).
Since NO diffuses from its site of production and is able
o cross membranes, its effects are dependent on the
istance that it can travel from its site of synthesis and the
ocation of sGC. Ding and Weinberg (2006) have reported
that the 1 subunit of sGC is present throughout the dorsal
horn, and is expressed by NK1 receptor-expressing pro-
jection neurons in lamina I, as well as by both excitatory
and inhibitory interneurons in the superficial laminae. In-
terestingly, although nNOS- and sGC-immunoreactive
structures were frequently found in contact with each
other, in most cases both structures lacked synaptophysin
(a marker for axonal boutons), suggesting NO-mediated
dendro-dendritic interactions. However, some nNOS-con-
taining axons were associated with sGC-containing pro-
files, and this arrangement presumably underlies the pre-
synaptic actions of NO. Taken together with the findings of
Valtschanoff et al. (1992b) the present results indicate that
the axons in this situation are nearly all GABAergic, and
these are presumably derived from local inhibitory in-
terneurons that show strong nNOS immunoreactivity. In
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boutons that were in contact with nNOS profiles. If some of
these boutons are glutamatergic, this arrangement could
underlie the post-synaptic actions of NO described above.
Our finding that nNOS was present in GABA-immunoreac-
tive and GABA-negative cells indicates that this mecha-
nism could operate at synapses on both inhibitory and
excitatory interneurons.
Several studies have found up-regulation of nNOS in
neurons in the dorsal horn during the development of
inflammatory pain states, and it has been reported that
there is an increase in the number of immunoreactive cells,
suggesting de novo expression (Herdegen et al., 1994;
onehara et al., 1997; Maihöfner et al., 2000; Chu et al.,
005). However, since we saw many neurons with very
eak nNOS immunoreactivity, it is possible that the appar-
nt increase in numbers of immunoreactive cells reported
n these studies is due to an up-regulation of nNOS in
nterneurons that normally express it at very low levels.
CONCLUSION
Laminae I–III of the dorsal horn contain a large number of
inhibitory and excitatory interneurons, and in order to un-
derstand their roles in neuronal circuits we need to identify
functional populations within each of these broad groups.
Although morphological and electrophysiological ap-
proaches have defined certain distinct types, for example
GABAergic islet cells and glutmatergic vertical and radial
cells in lamina II (Grudt and Perl, 2002; Maxwell et al.,
2007; Graham et al., 2007; Yasaka et al., 2010), many of
the inhibitory and excitatory interneurons have defied clas-
sification. This region is also highly complex in terms of its
neurochemistry, since the expression of neuropeptides,
certain receptors, calcium-binding proteins and several en-
zymes is restricted to specific populations of neurons
(Todd, 2010). Despite this complexity, the use of appropri-
ate combinations of neurochemical markers has allowed
us to define discrete classes of inhibitory and excitatory
interneurons, and some of these have been shown to be
selective in their postsynaptic targets (Polgár et al., 1999b,
2011; Puskár et al., 2001). It will be important in future
studies to integrate the results obtained from morphologi-
cal and physiological studies with these neurochemical
findings, for example by carrying out electrophysiological
recordings from mice in which expression of GFP is linked
to different neurochemical markers that define populations
of interneurons in the superficial dorsal horn.
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